Teva Pharmaceuticals has agreed to pay $450m to settle allegations that it violated several government acts and a raft of ...
As part of the settlement, there was no admission ... the department said. Separately, Teva agreed to resolve allegations that it conspired with other generic drug manufacturers to fix prices ...
The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
The settlement resolved two alleged kickback schemes: Medicare Cost-Sharing Scheme and Copay Assistance Foundations First, Teva has agreed to resolve allegations in a complaint the United States ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve allegations of violating the False Claims Act and Anti-Kickback Statute ...
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
South Dakota will receive almost $300,000 as part of a settlement with global health company Apotex and Teva Pharmaceuticals ...
TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). The settlement ...